Healthcare decisions and product labeling: Results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine

American Journal of Medicine

Volumn 102, Issue 2 A, 1997, Pages 50-56

  Friedman, Carola P ^a   Romeo, Daniel ^a   Hinton, Sandra Smith ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON PRESCRIPTION DRUG;

ADULT; COMPREHENSION; CONTROLLED STUDY; DRUG LABELING; DRUG PACKAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SELF MEDICATION;

EID: 0030933736     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00468-3     Document Type: Article

References (19)

1. Stuart B, Grana J. Are prescribed and over-the-counter medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly. Med Care. 1995;33:487-501.
2. Madhavan S, Schondelmeyer SW. Pharmacists' evaluations of the nonprescription availability of metaproterenol, cimetidine, ibuprofen, and nystatin. Am J Hosp Pharm. 1989;46:2486-2492.
3. McGill HC Jr, McMahan CA, Kruski AW, Mott GE. Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons. Arteriosclerosis. 1981;1:3-12.
4. Kusumi Y, Scanu AM, McGill HC, Wissler RW. Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a). Atherosclerosis. 1993;99:165-174.
5. Castelli WP, Garrison RJ, Wilson PWF, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256:2835-2838.
6. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990;2644:3007-3012.
7. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of Hyperlipidemias (POSCH). N Engl J Med. 1990;323:946-955.
8. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
9. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
10. Frick MH, Elo MO, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987;317:1237-1245.
11. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
12. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
13. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
14. Scandinavian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
15. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet. 1992;339:563-569.
16. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009-3014.
17. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary; September 1993. National Institutes of Health, National Heart, Lung, and Blood Institute publication 93-3096.
18. Health care practices and perceptions. A consumer survey of self-medication. Prepared for The Proprietary Association by Harry Heller Research Corporation, 1994.
19. Kincaid PJ, et al. Derivation of new readability formulas (automated readability index, fog count and Flesch Reading Ease Formula) for Navy enlisted personnel. Naval Technical Training, February 1975.